These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 20440292)

  • 1. Early identification of cardiovascular risk using genomics and proteomics.
    Kullo IJ; Cooper LT
    Nat Rev Cardiol; 2010 Jun; 7(6):309-17. PubMed ID: 20440292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putting it into perspective: multimarker panels for cardiovascular disease risk assessment.
    Taqui S; Daniels LB
    Biomark Med; 2013 Apr; 7(2):317-27. PubMed ID: 23547825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics of cardiovascular disease.
    Manace LC; Godiwala TN; Babyatsky MW
    Mt Sinai J Med; 2009 Dec; 76(6):613-23. PubMed ID: 20014425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases.
    López-Pedrera C; Barbarroja N; Aguirre MA; Torres LA; Velasco F; Cuadrado MJ
    Lupus; 2008 Oct; 17(10):904-15. PubMed ID: 18827055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.
    Ganesh SK; Skelding KA; Mehta L; O'Neill K; Joo J; Zheng G; Goldstein J; Simari R; Billings E; Geller NL; Holmes D; O'Neill WW; Nabel EG
    Pharmacogenomics; 2004 Oct; 5(7):952-1004. PubMed ID: 15469413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNV Association of Diverse Clinical Phenotypes from eMERGE reveals novel disease biology underlying cardiovascular disease.
    Glessner JT; Li J; Desai A; Palmer M; Kim D; Lucas AM; Chang X; Connolly JJ; Almoguera B; Harley JB; Jarvik GP; Ritchie MD; Sleiman PMA; Roden DM; Crosslin D; Hakonarson H
    Int J Cardiol; 2020 Jan; 298():107-113. PubMed ID: 31447229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs within the continuum of postgenomics biomarker discovery.
    Mayr M; Zampetaki A; Willeit P; Willeit J; Kiechl S
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):206-14. PubMed ID: 23325478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics meets clinical informatics.
    Smith J; Protti D
    Stud Health Technol Inform; 2005; 116():27-32. PubMed ID: 16160231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular genomics: outcomes and implications.
    Herrington DM
    Can J Cardiol; 2010 Mar; 26 Suppl A():60A-63A. PubMed ID: 20386764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized Management of Cardiovascular Disorders.
    Jain KK
    Med Princ Pract; 2017; 26(5):399-414. PubMed ID: 28898880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating Genomic Advances to Physical Therapist Practice: A Closer Look at the Nature and Nurture of Common Diseases.
    Curtis CL; Goldberg A; Kleim JA; Wolf SL
    Phys Ther; 2016 Apr; 96(4):570-80. PubMed ID: 26637647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact and influence of "omics" technology on hyper tension studies.
    Costa A; Franco OL
    Int J Cardiol; 2017 Feb; 228():1022-1034. PubMed ID: 27931010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GENOMICS AND SYSTEMS BIOLOGY APPROACHES IN THE STUDY OF LIPID DISORDERS.
    Rodríguez A; Pajukanta P
    Rev Invest Clin; 2018; 70(5):217-223. PubMed ID: 30307448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Genomics Is Personalizing the Management of Dyslipidemia and Cardiovascular Disease Prevention.
    Benes LB; Brandt DJ; Brandt EJ; Davidson MH
    Curr Cardiol Rep; 2018 Oct; 20(12):138. PubMed ID: 30328514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of genome-wide association studies on the pathophysiology and therapy of cardiovascular disease.
    Kessler T; Vilne B; Schunkert H
    EMBO Mol Med; 2016 Jul; 8(7):688-701. PubMed ID: 27189168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family history of coronary heart disease and markers of subclinical cardiovascular disease: where do we stand?
    Pandey AK; Pandey S; Blaha MJ; Agatston A; Feldman T; Ozner M; Santos RD; Budoff MJ; Blumenthal RS; Nasir K
    Atherosclerosis; 2013 Jun; 228(2):285-94. PubMed ID: 23578356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvements to cardiovascular gene ontology.
    Lovering RC; Dimmer EC; Talmud PJ
    Atherosclerosis; 2009 Jul; 205(1):9-14. PubMed ID: 19046747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics in hypertension and other cardiovascular diseases.
    Delles C; Neisius U; Carty DM
    Ann Med; 2012 Jun; 44 Suppl 1():S55-64. PubMed ID: 22713150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomics and cardiovascular drug development.
    Plump AS; Lum PY
    J Am Coll Cardiol; 2009 Mar; 53(13):1089-100. PubMed ID: 19324252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.